Catalyst Health Solutions Appoints Timothy Pearson as CFO

Catalyst Health Solutions has appointed Timothy Pearson as chief financial officer (CFO) and executive vice president (EVP), effective 22 August 2011. Pearson currently serves as CFO and EVP of MedImmune, the global biologics business for AstraZeneca, where he has functional responsibility for finance, information technology, strategic planning and governance, and is a member of MedImmune’s executive team.

Pearson joined MedImmune in 1998 and prior to his promotion to CFO in 2007, was vice president (VP) of finance and treasurer with responsibility for treasury, corporate finance, tax, risk management, Sarbanes-Oxley (SOX) compliance, internal audit and equity plan administration. During his tenure at MedImmune, Pearson raised over US$1.6bn in debt and was a key leader in merger and acquisition (M&A) transactions and related post acquisition integration, including the US$500m acquisition of US Bioscience and the US$1.6bn acquisition of Aviron. Pearson is a founding officer and investment committee member of MedImmune Ventures and chairman of MedImmune’s business excellence team.

Pearson, a certified public accountant (CPA), holds dual BSc degrees in business administration from the University of Delaware and accounting from the University of Maryland, as well as an MSc degree in finance from Loyola University.


Related reading